Kalvista Pharmaceuticals Inc (KALV)
R&D Expenses
$48.42M
TTM · Period ending: · USD
KALV R&D Expenses
Latest reported$48.42Mperiod ending
Latest reported$48.42Mperiod ending
KALV TTM R&D Expenses ($8.29M → $48.42M)
TTM R&D Expenses
High-resolution chart · PNG
KALV r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 48,424,500 | |
| 55,466,000 | |
| 55,640,000 | |
| 60,257,000 | |
| 71,709,000 | |
| 81,066,000 | |
| 90,995,000 | |
| 93,474,000 | |
| 86,167,000 | |
| 84,870,000 | |
| 82,410,000 | |
| 81,398,000 | |
| 80,277,000 | |
| 75,539,000 | |
| 75,214,000 | |
| 74,683,000 | |
| 70,166,000 | |
| 62,830,000 | |
| 52,189,000 | |
| 43,791,000 | |
| 41,287,000 | |
| 38,895,000 | |
| 41,031,000 | |
| 41,672,000 | |
| 40,193,000 | |
| 41,847,000 | |
| 38,264,000 | |
| 36,351,000 | |
| 35,021,000 | |
| 29,734,000 | |
| 26,632,000 | |
| 23,117,000 | |
| 18,237,000 | |
| 15,381,000 | |
| 14,172,000 | |
| 10,143,000 | |
| 6,999,000 | |
| 7,535,000 | |
| 8,456,000 | |
| 11,657,000 | |
| 15,829,000 | |
| 16,199,000 | |
| 14,970,000 | |
| 13,525,000 | |
| 10,771,000 | |
| 8,294,000 | |
| 6,379,000 |